Annual report pursuant to Section 13 and 15(d)

Note 3 - Supplemental Balance Sheet and Cash Flow Information (Tables)

v3.7.0.1
Note 3 - Supplemental Balance Sheet and Cash Flow Information (Tables)
12 Months Ended
Jun. 30, 2017
Notes Tables  
Schedule of Inventory, Current [Table Text Block]
 
 
June 30,
 
 
 
2017
 
 
2016
 
                 
Raw materials
  $
22,074
    $
18,685
 
Finished goods
   
38,077
     
38,417
 
Inventories, net
  $
60,151
    $
57,102
 
Property, Plant and Equipment [Table Text Block]
 
 
June 30,
 
 
 
2017
 
 
2016
 
Cost:
               
Land
  $
6,270
    $
6,270
 
Buildings and improvements
   
158,495
     
157,963
 
Machinery, equipment and other
   
98,596
     
82,018
 
Property and equipment
   
263,361
     
246,251
 
Accumulated depreciation and amortization
   
(128,237
)
   
(113,889
)
Property and equipment, net
  $
135,124
    $
132,362
 
Schedule of Intangible Assets and Goodwill [Table Text Block]
 
 
 
 
   
 
 
June 30,
 
 
 
Useful Life
(years)
 
 
2017
 
 
2016
 
                             
Developed technology
   
9
-
15
    $
276,959
    $
120,611
 
Trade names
   
5
-
20
     
87,092
     
63,706
 
Customer relationships
   
9
-
16
     
204,243
     
191,118
 
Non-compete agreement
   
3
-
5
     
3,264
     
3,284
 
Patents
   
 
10
 
     
633
     
-
 
Intangible assets
   
 
 
 
     
572,191
     
378,719
 
Accumulated amortization
   
 
 
 
     
(120,149
)
   
(75,595
)
Amortizable intangible assets, net
   
 
 
 
    $
452,042
    $
303,124
 
In process research and development
   
 
 
 
     
-
     
7,400
 
Intangible assets, net
   
 
 
 
    $
452,042
    $
310,524
 
Schedule of Finite-Lived Intangible Assets [Table Text Block]
 
 
June 30,
 
 
 
2017
 
 
2016
 
                 
Beginning balance
  $
310,524
    $
292,839
 
Acquisitions
   
185,869
     
53,500
 
Other additions
   
976
     
-
 
Amortization expense
   
(44,393
)
   
(29,395
)
Currency translation
   
(934
)
   
(6,420
)
Ending balance
  $
452,042
    $
310,524
 
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]
2018
  $
44,825
 
2019
   
44,171
 
2020
   
43,538
 
2021
   
43,180
 
2022
   
41,491
 
Thereafter
   
234,837
 
Total
  $
452,042
 
Schedule of Goodwill [Table Text Block]
 
 
Biotechnology
 
 
Diagnostics
 
 
Protein
Platforms
 
 
Total
 
June 30, 2015
  $
115,198
    $
60,601
    $
214,839
    $
390,638
 
Acquisitions (Note 2)
   
-
     
42,669
     
6,878
     
49,547
 
Prior year acquisitions (Note 2)
   
-
     
-
     
-
     
-
 
Currency translation
   
(6,475
)
   
-
     
(2,828
)
   
(9,303
)
June 30, 2016
  $
108,723
    $
103,270
    $
218,889
    $
430,882
 
Acquisitions (Note 2)
   
147,484
     
 
     
 
     
147,484
 
Prior year acquisitions (Note 2)
   
-
     
-
     
1,809
     
1,809
 
Currency translation
   
(1,277
)
   
-
     
128
     
(1,149
)
June 30, 2017
  $
254,930
    $
103,270
    $
220,826
    $
579,026
 
Schedule of Other Assets, Noncurrent [Table Text Block]
 
 
June 30,
 
 
 
2017
 
 
2016
 
                 
Investments
  $
40,385
    $
385
 
Other
   
3,617
     
1,537
 
    $
44,002
    $
1,922
 
Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]
 
 
Year Ended June 30,
 
 
 
2017
 
 
2016
 
 
2015
 
Income taxes paid
  $
42,900
    $
44,900
    $
42,600
 
Interest paid
   
7,452
     
1,661
     
1,544
 
Non-cash activities:
                       
Acquisition-related liabilities (1)
   
32,856
     
42,259
     
43,048